Gracell Biotechnologies Inc.: cashflow_investing
| Value | {"amount": -7008000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | Gracell Biotechnologies Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/22313909-ad98-44ca-b0e2-ef0f5081ad63
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-23-049599Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001826492/cashflow-investing/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/22313909-ad98-44ca-b0e2-ef0f5081ad63
History
- supersedes {"unit": "CNY", "value": -48332000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities"} (evidence 0001104659-23-049599)